Rheumatoid Arthritis Clinical Trials in Chicago

Showing 1381-1400 of 1,857 trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01613599

This prospective observational study will evaluate the long-term safety of MabThera/Rituxan (rituximab) in participants with granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis. Data will be collected for a maximum of 4 years from participants initiated on MabThera/Rituxan therapy by their physician according to prescribing information.

Granulomatosis With PolyangiitisMicroscopic Polyangiitis

Genentech, Inc.100 participantsStarted Jun 2012

Scottsdale, Arizona, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +12 more locations

COMPLETED2.2 miles

Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma

NCT00091091

RATIONALE: Assessing the long-term effects of cancer treatment in cancer survivors may help improve the ability to plan effective treatment and follow-up care. PURPOSE: This clinical trial is studying the long-term effects of treatment in patients who were previously treated for childhood Hodgkin's lymphoma.

Long-term Effects Secondary to Cancer Therapy in ChildrenLymphoma

Children's Oncology Group530 participantsStarted Dec 2004

Palo Alto, California, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +12 more locations

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma

Rheumatoid Arthritis Trials in Other Cities

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

TARGET Intracranial Aneurysm Coiling Registry

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

OLIF25™ /OLIF51™ Study

Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

Other Conditions in Chicago